Peripheral blood transcriptomics may facilitate the classification of asthma inflammatory subtypes, and the identified biomarkers hold potential for non-invasive phenotyping and precision management.
Zhou et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: